News

Vivolux said vast amounts of defective proteins formed in tumor cells disrupt the functioning of proteasome. The new mechanism of action by VLX1570 has been indicated to inhibit

Entresto is indicated to lower the risk of cardiovascular mortality and morbidity in patients with heart failure with reduced ejection fraction (HfrEF). It improves the protective neurohormonal systems

Appreciating the importance of the U.S. biotechnology and pharmaceutical market, Selvita decided to come closer to its partners and clients and open a fully-owned US subsidiary, Selvita Inc.

It is the result of over 150 million euro worth of investment with creation of 100 highly skilled jobs. In attendance at the event were Austrian dignitaries from

The alliance will combine Clinigen’s and Cumberland’s respective strengths, expertise and geographical footprints to maximize the commercial potential of future products. As part of Clinigen’s continuing strategy to

his announcement was made at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival, September 16-19, 2015 in New York, NY. VISTA (V-Domain Ig Suppressor of

Amgen has agreed to acquire all outstanding shares of Dezima for up to $1.55bn from Forbion and other current shareholders, subject to obtaining U.S. Federal Trade Commission clearance.

ALLDocs, also known as The Association of LensCrafters Leaseholding Doctors, is the second largest independent optometry group in the U.S. It works closely with its LensCrafters partners. "This

Under the terms of the agreement, CICT will utilize Cesca’s newest evolution of the AutoXpress® platform under the Company’s "Early Technology Access Program". Specifically, this latest innovation of